Tag Archives: pediatrics

October, 2018

August, 2018

May, 2018

December, 2017

May, 2017

April, 2017

March, 2017

December, 2016

November, 2016

  • 7 November

    FDA Expands Approval of Enbrel for Use in Children with Plaque Psoriasis

    THOUSAND OAKS, Calif., Nov. 4, 2016 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the expanded use of ENBREL® (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque …